Patents by Inventor Audrey Davies

Audrey Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer
    Patent number: 8486966
    Abstract: The present invention relates to compounds of Formula (I): and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: July 16, 2013
    Assignee: Astrazeneca AB
    Inventors: Audrey Davies, Stephanos Ioannidis, Michelle Lamb, Mei Su, Tao Wang, Hai-Jun Zhang
  • Pyrazolylaminopyridine derivatives useful as kinase inhibitors
    Patent number: 8324252
    Abstract: This invention relates to novel compounds having the Formula (I) to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
    Type: Grant
    Filed: February 1, 2006
    Date of Patent: December 4, 2012
    Assignee: Astrazeneca AB
    Inventors: Audrey Davies, Michelle Lamb, Paul Lyne, Tao Wang, Dingwei Yu, Peter Mohr, Bin Wang
  • 9-(PYRAZOL-3-YL)-9H-PURINE-2-AMINE AND 3-(PYRAZOL-3-YL) -3H-IMIDAZO[4,5-B] PYRIDIN-5- AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20100324040
    Abstract: The present invention relates to compounds of Formula (I): and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.
    Type: Application
    Filed: May 2, 2008
    Publication date: December 23, 2010
    Applicant: ASTRAZENECA AB
    Inventors: Audrey Davies, Stephanos Ioannidis, Michelle Lamb, Mei Su, Tao Wang, Hai-Jun Zhang
  • 5-AMINOPYRAZOL-3-YL-3H-IMIDAZO (4,5-B) PYRIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
    Publication number: 20100204246
    Abstract: The present invention relates to compounds of Formula (I) and to their pharmaceutical compositions, and to their methods of use. These novel compounds provide a treatment for myeloproliferative disorders and cancer.
    Type: Application
    Filed: April 17, 2008
    Publication date: August 12, 2010
    Applicant: AstraZeneca AB
    Inventors: Audrey Davies, Stephanos Ioannidis, Michelle Lamb, Tao Wang, Hai-Jun Zhang
  • ENANTIOMERS OF SELECTED FUSED HETEROCYCLICS AND USES THEREOF
    Publication number: 20090099210
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: December 22, 2008
    Publication date: April 16, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Brian Aquila, Michael Howard Block, Audrey Davies, Jayachandran Ezhuthachan, Sandra Ann Filla, Timothy Pontz, Daniel John Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Enantiomers of selected fused heterocyclics and uses thereof
    Patent number: 7498333
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Grant
    Filed: August 18, 2005
    Date of Patent: March 3, 2009
    Assignee: AstraZeneca AB
    Inventors: Brian Aquila, Michael Howard Block, Audrey Davies, Jayachandran Ezhuthachan, Sandra Ann Filla, Timothy Pontz, Daniel John Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of Cancer
    Publication number: 20080293744
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 16, 2005
    Publication date: November 27, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Brian Aquila, Michael Howard Block, Audrey Davies, Jayachandran Ezhuthachan, Timothy Pontz, Daniel John Russell, Marie-Elena Theoclitou, XiaoLan Zheng
  • NOVEL FUSED HETEROCYCLES AND USES THEREOF
    Publication number: 20080153854
    Abstract: This invention relates to novel compounds having the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: February 15, 2008
    Publication date: June 26, 2008
    Applicant: AstraZeneca AB
    Inventors: Brian Aquila, Michael Howard Block, Audrey Davies, Jayachandran Ezhuthachan, Sandra Filla, Richard William Luke, Timothy Pontz, Daniel John Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Pyrazolylaminopyridine Derivatives Useful as Kinases Inhibitors
    Publication number: 20080139561
    Abstract: This invention relates to novel compounds having the Formula (I) to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
    Type: Application
    Filed: February 1, 2006
    Publication date: June 12, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Audrey Davies, Michelle Lamb, Paul Lyne, Tao Wang, Dingwei Yu, Peter Mohr, Bin Wang
  • Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer
    Publication number: 20070287703
    Abstract: Compounds which possess Eg5 inhibitory activity and are useful for their anti-cell-proliferation (such as anti-cancer) activity and thus in methods of treatment of the human or animal body are described.
    Type: Application
    Filed: July 21, 2005
    Publication date: December 13, 2007
    Applicant: AstraZeneca AB
    Inventors: Michael Block, Audrey Davies, Daniel Russell, Marie-Elena Theoclitou
  • Selected Fused Heterocyclics and Uses Thereof
    Publication number: 20070249636
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 16, 2005
    Publication date: October 25, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Brian Aquila, Michael Block, Audrey Davies, Jayachandran Ezhuthachan, Timothy Pontz, Daniel Russell, Marie-Elena Theoclitou, XiaoLan Zheng
  • Novel fused heterocycles and uses thereof
    Publication number: 20060063751
    Abstract: This invention relates to novel compounds having the formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 18, 2005
    Publication date: March 23, 2006
    Applicant: AstraZeneca AB
    Inventors: Brian Aquila, Michael Block, Audrey Davies, Jayachandran Ezhuthachan, Sandra Filla, Richard Luke, Timothy Pontz, Daniel Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Selected fused heterocyclics and uses thereof
    Publication number: 20060041128
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 18, 2005
    Publication date: February 23, 2006
    Applicant: AstraZeneca AB
    Inventors: Brian Aquila, Michael Block, Audrey Davies, Jayachandran Ezhuthachan, Timothy Pontz, Daniel Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Enantiomers of selected fused heterocyclics and uses thereof
    Publication number: 20060041129
    Abstract: This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.
    Type: Application
    Filed: August 18, 2005
    Publication date: February 23, 2006
    Applicant: AstraZeneca AB
    Inventors: Brian Aquila, Michael Howard Block, Audrey Davies, Jayachandran Ezhuthachan, Timothy Pontz, Daniel John Russell, Maria-Elena Theoclitou, XiaoLan Zheng
  • Method and system for performing an asymmetric bus arbitration protocol within a data processing system
    Patent number: 5692135
    Abstract: An arbitration protocol, preferably known as data-valid extended (DVE) protocol, for determining which one of the two units within a computer system may obtain access to a common bus is described. The DVE protocol is based on a point-to-point communication between two peer units. The DVE protocol is a physical level signalling convention for controlling switch communications on bi-directional address buses and data buses in a boundary-latched synchronous environment. The DVE protocol is asymmetric, yet fair, and is designed to minimize the number of cycles spent (or latency) in accessing the address or data buses and to maximize the number useful cycles (or bandwidth) on the address buses as well as the data buses. The asymmetry of the DVE protocol reduces the number of cycles spent in arbitration to zero for any data transfer size greater than one.
    Type: Grant
    Filed: December 14, 1995
    Date of Patent: November 25, 1997
    Assignee: International Business Machines Corporation
    Inventors: Manuel Joseph Alvarez, II, Gregory Alan Hughes, Jeffrey Thomas Kreulen, Audrey Davis Romonosky, Sanjay Raghunath Deshpande
  • Method and apparatus for applying and blending in eye shadow
    Patent number: 4936325
    Abstract: A method and apparatus for applying and blending on a human upper eyelid various shades of one or more of eye shadows. The method includes applying two or more shades in individual segments on the upper eyelid and blending in all together. The apparatus is made of a flexible material, and includes a cut-out section and a recess section separated by a thin partition wall for applying various shades of eye shadows therethrough. The device is contoured to fit within the bone structure above the eye of a person and includes holding flaps with pressure-sensitive adhesive back-layers for temporarily securing it on the face of the person. Two markings are provided for aligning the device with the outer curvature of the upper eyelid of the user.
    Type: Grant
    Filed: November 21, 1988
    Date of Patent: June 26, 1990
    Inventor: Audrey Davis